ResMed Inc. (ASX:RMD)

Market Cap	64.48B
Revenue (ttm)	7.85B
Net Income (ttm)	2.14B
Shares Out	n/a
EPS (ttm)	14.51
PE Ratio	30.18
Forward PE	26.35
Dividend	0.50 (1.16%)
Ex-Dividend Date	Aug 13, 2025

Volume	870,339
Average Volume	1,126,843
Open	43.84
Previous Close	43.55
Day's Range	43.76 - 44.10
52-Week Range	32.04 - 45.01
Beta	0.77
RSI	67.50
Earnings Date	Jul 31, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 9,980
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: RMD

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD